Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minoxidil + retinaldehyde nanoparticle solution for androgenetic alopecia
TCTR20201104003Phase 3Recruiting
- Sponsor
- ermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minoxidil, retinaldehyde in androgenetic alopecia (AGA), sponsored by ermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital. Started Nov 2020; status: recruiting.
02
Drugs
minoxidilretinaldehyde
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on TCTR20201104003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201104003.